Traded Mar 13 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Traded Feb 13, 2026 · Filed Feb 18, 2026
Bruker's EXEC VP&PRES BRUKER NANO INC. sold $74K of Bruker shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$73,880
Shares × reported transaction price
1 day after results of Feb 12, 2026, 82 days before results of May 6, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +5.8% | +0.7% | +5.1% |
| 30 days | −10.1% | −4.3% | −5.8% |
| 90 days | +14.2% | +8.3% | +5.9% |
| 180 days | +46.7% | +12.1% | +34.6% |
Past results only. Not a forecast.
Traded Mar 13 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Mark Munch (EXEC VP&PRES BRUKER NANO INC.) sold ~$71K of Bruker
Scheduled in advanceTraded Mar 13 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.